PSYENCE BIOMEDICAL LTD

PBM Shares Surge 6.6% to $4.12 as Psyence Biomedical Gains Momentum in April 2026

Explore Psyence Biomedical’s latest trading update, market data, and upcoming AGM details – understand the stock’s 6.6% rise and 25.9% recent decline.

PSYENCE BIOMEDICAL LTD
Canada
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

23/10/2026, 15:20

2 minutes to read

PBM Stock Surges 6.6% as Psyence Biomedical Secures FDA‑Ready Ibogaine Milestones

Discover how Psyence Biomedical’s latest milestones and investor confidence signal a bullish future for its ibogaine program—an insider’s view on potential upside.

PSYENCE BIOMEDICAL LTD
Canada
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

22/10/2026, 23:42

3 minutes to read